Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 5, 2014, Pages 906-914

  Nilsen, Linn Hege ^a   Witter, Menno P ^a   Sonnewald, Ursula ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

dementia; GABA; glutamate; MR spectroscopy; neurotransmitters

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; AMINO ACID RECEPTOR AFFECTING AGENT; AMYLOID BETA PROTEIN; ASPARTIC ACID; GLUTAMIC ACID; GLUTAMINE; PYRUVIC ACID;

ALZHEIMER DISEASE; AMINO ACID SYNTHESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CARBON NUCLEAR MAGNETIC RESONANCE; CARBOXYLATION; CELL INTERACTION; CELL METABOLISM; CINGULATE GYRUS; CITRIC ACID CYCLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; FRONTAL CORTEX; GLIA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HOMEOSTASIS; NONHUMAN; POSTERIOR CINGULATE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RETROSPLENIAL CORTEX; TEMPORAL LOBE;

ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; BRAIN; CITRIC ACID CYCLE; DISEASE MODELS, ANIMAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; NEURONS; PYRUVIC ACID; RATS; RATS, TRANSGENIC; RATS, WISTAR;

EID: 84899917349     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.37     Document Type: Article

References (41)

1. Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 2005; 57: 695-703.
2. Butterworth RF, Besnard AM. Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metab Brain Dis 1990; 5: 179-184.
3. Valla J, Berndt JD, Gonzalez-Lima F. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 2001; 21: 4923-4930.
4. Fayed N, Modrego PJ, Rojas-Salinas G, Aguilar K. Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study. Am J Alzheimers Dis Other Demen 2011; 26: 450-456.
5. Lin AP, Shic F, Enriquez C, Ross BD. Reduced glutamate neurotransmission with Alzheimer's disease-an in vivo C-13 magnetic resonance spectroscopy study. Magn Reson Mater Phy 2003; 16: 29-42.
6. Tiwari V, Patel AB. Impaired glutamatergic and GABAergic function at early age in Abeta PPswe-PS1dE9 mice: implications for Alzheimer's disease. J Alzheimers Dis 2012; 28: 765-769.
7. Schubert D, Soucek T, Blouw B. The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur J Neurosci 2009; 29: 1323-1334.
8. Sailasuta N, Harris K, Tran T, Ross B. Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study. Neuropsychiatr Dis Treat 2011; 7: 495-499.
9. Allaman I, Gavillet M, Belanger M, Laroche T, Viertl D, Lashuel HA et al. Amyloidbeta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 2010; 30: 3326-3338.
10. Leon WC, Canneva F, Partridge V, Allard S, Ferretti MT, DeWilde A et al. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays preplaque intracellular amyloid-beta-associated cognitive impairment. J Alzheimers Dis 2010; 20: 113-126.
11. Nilsen LH, Melo TM, Saether O, Witter MP, Sonnewald U. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo (1) H MRS study. J Neurochem 2012; 123: 532-541.
12. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42: 85-94.
13. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease-FDG-PET studies in MCI and AD. Eur J Nucl Med Mol I 2005; 32: 486-510.
14. Nilsen LH, Shi Q, Gibson GE, Sonnewald U. Brain [U-13 C]glucose metabolism in mice with decreased alpha-ketoglutarate dehydrogenase complex activity. J Neurosci Res 2011; 89: 1997-2007.
15. Badar-Goffer RS, Bachelard HS, Morris PG. Cerebral metabolism of acetate and glucose studied by 13C-n.m.r. spectroscopy. A technique for investigating metabolic compartmentation in the brain. Biochem J 1990; 266: 133-139.
16. Alvestad S, Hammer J, Qu H, Haberg A, Ottersen OP, Sonnewald U. Reduced astrocytic contribution to the turnover of glutamate, glutamine, and GABA characterizes the latent phase in the kainate model of temporal lobe epilepsy. J Cereb Blood Flow Metab 2011; 31: 1675-1686.
17. Nehlig A, Wittendorp-Rechenmann E, Lam CD. Selective uptake of [14C]2-deoxyglucose by neurons and astrocytes: high-resolution microautoradiographic imaging by cellular 14C-trajectography combined with immunohistochemistry. J Cereb Blood Flow Metab 2004; 24: 1004-1014.
18. Qu H, Haberg A, Haraldseth O, Unsgard G, Sonnewald U. (13)C MR spectroscopy study of lactate as substrate for rat brain. Dev Neurosci 2000; 22: 429-436.
19. Waniewski RA, Martin DL. Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci 1998; 18: 5225-5233.
20. Hassel B, Bachelard H, Jones P, Fonnum F, Sonnewald U. Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate. J Cereb Blood Flow Metab 1997; 17: 1230-1238.
21. Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 2006; 98: 641-653.
22. Ottersen OP, Zhang N, Walberg F. Metabolic compartmentation of glutamate and glutamine: morphological evidence obtained by quantitative immunocytochemistry in rat cerebellum. Neuroscience 1992; 46: 519-534.
23. Ottersen OP, Storm-Mathisen J. Different neuronal localization of aspartate-like and glutamate-like immunoreactivities in the hippocampus of rat, guinea-pig and Senegalese baboon (Papio papio), with a note on the distribution of gammaaminobutyrate. Neuroscience 1985; 16: 589-606.
24. Qu H, Eloqayli H, Muller B, Aasly J, Sonnewald U. Glial-neuronal interactions following kainate injection in rats. Neurochem Int 2003; 42: 101-106.
25. Mosconi L, Sorbi S, Nacmias B, De Cristofaro MT, Fayyaz M, Cellini E et al. Brain metabolic differences between sporadic and familial Alzheimer's disease. Neurology 2003; 61: 1138-1140.
26. Hoyer S, Oesterreich K, Wagner O. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J Neurol 1988; 235: 143-148.
27. Salek RM, Xia J, Innes A, Sweatman BC, Adalbert R, Randle S et al. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem Int 2010; 56: 937-947.
28. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2009; 106: 14670-14675.
29. Gueli MC, Taibi G. Alzheimer's disease: amino acid levels and brain metabolic status. Neurol Sci 2013; 34: 1575-1579.
30. Hertz L, Yu AC, Kala G, Schousboe A. Neuronal-astrocytic and cytosolic-mitochondrial metabolite trafficking during brain activation, hyperammonemia and energy deprivation. Neurochem Int 2000; 37: 83-102.
31. Nestor PJ, Fryer TD, Ikeda M, Hodges JR. Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease). Eur J Neurosci 2003; 18: 2663-2667.
32. Hoyer S. Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol Chem Neuropathol 1992; 16: 207-224.
33. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 2009; 30: 1574-1586.
34. Casley CS, Land JM, Sharpe MA, Clark JB, Duchen MR, Canevari L. Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol Dis 2002; 10: 258-267.
35. Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 2002; 80: 91-100.
36. La Joie R, Perrotin A, Barre L, Hommet C, Mezenge F, Ibazizene M et al. Regionspecific hierarchy between atrophy, hypometabolism, and beta-amyloid (Abeta) load in Alzheimer's disease dementia. J Neurosci 2012; 32: 16265-16273.
37. Chantal S, Braun CM, Bouchard RW, Labelle M, Boulanger Y. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res 2004; 1003: 26-35.
38. Inoue R, Hashimoto K, Harai T, Mori H. NMDA-and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice. J Neurosci 2008; 28: 14486-14491.
39. Paula-Lima AC, De Felice FG, Brito-Moreira J, Ferreira ST. Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology 2005; 49: 1140-1148.
40. Santa-Maria I, Hernandez F, Moreno FJ, Avila J. Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation. Neurosci Lett 2007; 429: 91-94.
41. Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Res 2004; 1012: 60-65.